Ignite Creation Date:
2025-12-24 @ 9:40 PM
Ignite Modification Date:
2026-02-19 @ 11:35 AM
Study NCT ID:
NCT02257632
Status:
COMPLETED
Last Update Posted:
2019-05-07
First Post:
2014-10-02
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Systemic Vascular Endothelial Growth Factor (VEGF) Protein Dynamics Following Intravitreal Injections of Ranibizumab Versus Aflibercept in Patients With Neovascular Age-related Macular Degeneration
Sponsor:
Novartis Pharmaceuticals
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2015-04-08
Start Date Type:
ACTUAL
Primary Completion Date:
2017-03-20
Primary Completion Date Type:
ACTUAL
Completion Date:
2017-06-08
Completion Date Type:
ACTUAL
First Submit Date:
2014-10-02
First Submit QC Date:
None
Study First Post Date:
2014-10-06
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2018-06-05
Results First Submit QC Date:
None
Results First Post Date:
2019-05-07
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2019-01-31
Last Update Post Date:
2019-05-07
Last Update Post Date Type:
ACTUAL